Clinical and Genetic Predictors of Glycemic Control and Weight Loss Response to Liraglutide in Patients with Type 2 Diabetes

Background: Evidence suggests a heterogeneous response to therapy with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in patients with type 2 diabetes mellitus (T2DM). The aim of this study is to identify the genetic and clinical factors that relate to glycemic control and weight loss respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyriakidou, Artemis, Kyriazou, Angeliki V., Koufakis, Theocharis, Vasilopoulos, Yiannis, Grammatiki, Maria, Tsekmekidou, Xanthippi, Avramidis, Iakovos, Baltagiannis, Stefanos, Goulis, Dimitrios G., Zebekakis, Pantelis, Kotsa, Kalliopi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955617/
https://www.ncbi.nlm.nih.gov/pubmed/35330424
http://dx.doi.org/10.3390/jpm12030424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955617/
https://www.ncbi.nlm.nih.gov/pubmed/35330424
http://dx.doi.org/10.3390/jpm12030424

Ejemplares similares